Diagnosis and treatment of testicular cancer

American Family Physician

Volumn 77, Issue 4, 2008, Pages

  Shaw, Joel ^a,b,c,d  

^a GRANT MEDICAL CENTER   (United States)

^b Grant Family Practice Residency   (United States)

^c Grant Primary Care Sports Medicine Fellowship Program

^d MAX Sports Medicine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLEOMYCIN SULFATE; CISPLATIN; ETOPOSIDE;

AZOOSPERMIA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR RISK; CRYPTORCHISM; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISSECTION; ECHOGRAPHY; FOLLOW UP; GENETIC LINKAGE; HUMAN; KIDNEY INJURY; LEUKEMIA; LUNG DISEASE; MALE INFERTILITY; MATERNAL SMOKING; NEUROPATHY; OBSERVATION; ORCHIECTOMY; OTOTOXICITY; PARAAORTIC LYMPH NODE; PHYSICAL EXAMINATION; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; SURVIVAL RATE; SURVIVAL TIME; TESTIS CANCER; TREATMENT PLANNING;

AGE FACTORS; CARDIOVASCULAR DISEASES; HUMANS; MALE; MEDICAL HISTORY TAKING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PHYSICAL EXAMINATION; PROGNOSIS; RISK FACTORS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 40149086410     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Bosl GJ, Motzer RJ. Testicular germ-cell cancer [published correction appears in N Engl J Med. 1997;337(19):1403]. N Engl J Med. 1997;337(4):242-253.
2. Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005;116(3):331-339.
3. Giwercman A, Carlsen E, Keiding N, Skakkebaek NE. Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect. 1993;(101 suppl 2):65-71.
4. Swerdlow AJ, Higgins CD, Pike MC. Risk of testicular cancer in cohort of boys with cryptochordism [published correction appears in BMJ. 1997;315(7116):1129]. BMJ. 1997;314(7093):1507-1511.
5. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356(18):1835-1841.
6. Dearnaley D, Huddart R, Horwich A. Regular review: managing testicular cancer. BMJ. 2001;322(7302):1583-1588.
7. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, eds. Cancer Incidence in Five Continents: Vol. VII. New York, NY: Oxford University Press; 1999.
8. Rapley EA, Crockford GP, Teare D, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet. 2000;24(2):197-200.
9. Raman JD, Nobert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol. 2005;174(5):1819-1822.
10. Jacobsen R, Bostofte E, Engholm G, et al. Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ. 2000;321(7264):789-792.
11. Strohsnitter WC, Noller KL, Hoover RN, et al. Cancer risk in men exposed in utero to diethylstilbestrol. J Natl Cancer Inst. 2001;93(7):545-551.
12. Weir HK, Marrett LD, Kreiger N, Darlington GA, Sugar L. Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer. 2000;87(3):438-443.
13. Coupland CA, Forman D, Chilvers CE, Davey G, Pike MC, Oliver RT. Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control. 2004;15(3):277-283.
14. Kaijser M, Akre O, Cnattingius S, Ekbom A. Maternal lung cancer and testicular cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev. 2003;12(7):643-646.
15. Srivastava A, Kreiger N. Cigarette smoking and testicular cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(1):49-54.
16. Horwich A, Shipley J, Huddart R. Testicular germ-cell cancer. Lancet. 2006;367(9512):754-765.
17. Screening for testicular cancer: update of the evidence for the U.S. Preventive Services Task Force. Rockville, Md.: Agency For Healthcare Research and Quality; 2004. http://www.ahrq.gov/clinic/3rduspstf/testicular/testiculrs. htm. Accessed September 25, 2007.
18. American Cancer Society. Can testicular cancer be found early? http://www.cancer.org/docroot/CRI/content/ CRI_2_4_3X_Can_Testicular_Cancer_Be_Found_Early_41.asp?rnav=cri. Accessed July 31, 2007.
19. Tseng A, Homing SJ, Freiha FS, Resser KJ, Hannigan JF, Torti FM. Gynecomastia in testicular cancer patients. Prognostic and therapeutic implications. Cancer. 1985;56(10):2534-2538.
20. American Cancer Society. How is testicular cancer staged? http://www.cancer.org/docroot /CRI /content / CRI_2_4_3X_How_is_testicular_cancer_staged_41.asp?rnav=cri. Accessed July 31, 2007.
21. Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol. 1994;12(1):120-126.
22. Bosl GJ, Gluckman R, Gellar NL, et al. VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors. J Clin Oncol. 1986;4(10):1493-1499.
23. Choyke PL, Bluth EI, Bush WH Jr, et al., for the Expert Panel on Urologic Imaging. American College of Radiology. Appropriateness criteria. Staging of testicular malignancy. http://www.acr.org/.../app_criteria/pdf/ ExpertPanelonUrologicImaging/StagingofTesticularMalignancyDoc18.aspx. Accessed September 25, 2007.
24. American Cancer Society. Treatment options by stage. http://www.cancer. org/docroot/CRI /content/CRI_2_4_4X_Treatment_Options_by_stage_41.asp?rnav=cri. Accessed July 31, 2007.
25. Toledano MB, Jarup L, Best N, Wakefield J, Elliot P. Spatial variation and temporal trends of testicular cancer in Great Britain. Br J Cancer. 2001;84(11):1482-1487.
26. Spermon JR, Roelveld TA, van der Poel HG, et al. Comparison of surveillance and retroperitoneal lymph node dissection in Stage I nonseminomatous germ cell tumors. Urology. 2002;59(6):923-929.
27. Chung PW, Gospodarowicz MK, Panzarella T, et al. Stage II testicular seminoma: patterns of recurrence and outcome of treatment. Eur Urol. 2004;45(6):754-759.
28. Bokemeyer C, Kollmannsberger C, Stenning S, et al. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. Br J Cancer. 2004;91(4):683-687.
29. Lampe H, Horwich A, Norman A, Nicholls J, Dearnaley DP. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol. 1997;15(1):239-245.
30. Huddart RA, Norman A, Shahidi M, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol. 2003;21(8):1513-1523.
31. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst. 1997;89(19):1429-1439.
32. Meinardi MT, Gietema JA, van der Graaf WT, et al. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol. 2000;18(8):1725-1732.
33. Fosså SD, Aass N, Harvei S, Tretli S. Increased mortality rates in young and middle-aged patients with malignant germ cell tumours. Br J Cancer. 2004;90(3):607-612.
34. Huddart RA, Norman A, Moynihan C, et al. Fertility, gonadal and sexual function in survivors of testicular cancer. Br J Cancer. 2005;93(2):200-207.
35. Fosså SD, Kravdal O. Fertility in Norwegian testicular cancer patients. Br J Cancer. 2000;82(3):737-741.
36. Fosså SD, Chen J, Schonfeld SJ, et al. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst. 2005;97(14):1056-1066.
37. American Cancer Society. Second cancers caused by cancer treatment. http://www.cancer.org/docroot /MBC/content / MBC_2X_Second_Cancers_Caused_By_Cancer_Treatment.asp?sitearea=&level=. Accessed July 31, 2007.